John Dornhoffer
Concepts (374)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tympanoplasty | 22 | 2020 | 57 | 7.450 |
Why?
| Cochlear Implantation | 10 | 2022 | 70 | 5.040 |
Why?
| Mastoid | 20 | 2019 | 51 | 5.000 |
Why?
| Cochlear Implants | 9 | 2022 | 58 | 4.500 |
Why?
| Hearing Loss, Conductive | 15 | 2019 | 52 | 3.920 |
Why?
| Hearing Aids | 9 | 2017 | 63 | 3.530 |
Why?
| Cholesteatoma, Middle Ear | 16 | 2017 | 33 | 3.020 |
Why?
| Ossicular Replacement | 12 | 2018 | 27 | 2.930 |
Why?
| Hearing Loss, Sensorineural | 11 | 2022 | 82 | 2.900 |
Why?
| Tinnitus | 13 | 2017 | 62 | 2.630 |
Why?
| Otologic Surgical Procedures | 12 | 2023 | 39 | 2.480 |
Why?
| Cartilage | 11 | 2020 | 47 | 2.400 |
Why?
| Stapes Surgery | 6 | 2020 | 21 | 2.330 |
Why?
| Treatment Outcome | 50 | 2022 | 5604 | 2.280 |
Why?
| Hearing Loss | 6 | 2023 | 84 | 2.120 |
Why?
| Transcranial Magnetic Stimulation | 10 | 2017 | 81 | 2.010 |
Why?
| Tympanic Membrane Perforation | 6 | 2020 | 19 | 2.000 |
Why?
| Ear Ossicles | 8 | 2017 | 16 | 1.940 |
Why?
| Retrospective Studies | 52 | 2023 | 6432 | 1.890 |
Why?
| Tympanic Membrane | 12 | 2020 | 39 | 1.880 |
Why?
| Hearing Loss, Unilateral | 4 | 2016 | 12 | 1.810 |
Why?
| Otorhinolaryngologic Surgical Procedures | 4 | 2019 | 35 | 1.690 |
Why?
| Ossicular Prosthesis | 8 | 2020 | 18 | 1.620 |
Why?
| Hearing | 9 | 2017 | 61 | 1.610 |
Why?
| Child | 44 | 2023 | 7341 | 1.590 |
Why?
| Ear Diseases | 5 | 2023 | 25 | 1.570 |
Why?
| Adolescent | 41 | 2023 | 6897 | 1.560 |
Why?
| Osseointegration | 3 | 2017 | 34 | 1.540 |
Why?
| Otolaryngology | 4 | 2019 | 58 | 1.440 |
Why?
| Postoperative Complications | 15 | 2019 | 1033 | 1.430 |
Why?
| Bone Conduction | 10 | 2017 | 25 | 1.410 |
Why?
| Humans | 115 | 2023 | 54284 | 1.400 |
Why?
| Adult | 62 | 2023 | 14207 | 1.390 |
Why?
| Male | 75 | 2022 | 27334 | 1.360 |
Why?
| Female | 75 | 2020 | 28441 | 1.320 |
Why?
| Ear Canal | 6 | 2013 | 16 | 1.300 |
Why?
| Meniere Disease | 8 | 2020 | 17 | 1.260 |
Why?
| Middle Aged | 51 | 2023 | 13088 | 1.230 |
Why?
| Child, Preschool | 24 | 2020 | 4147 | 1.200 |
Why?
| Aged | 41 | 2023 | 10054 | 1.160 |
Why?
| Patient Satisfaction | 3 | 2018 | 304 | 1.130 |
Why?
| Semicircular Canals | 3 | 2019 | 14 | 1.070 |
Why?
| Young Adult | 19 | 2023 | 4318 | 1.020 |
Why?
| Reoperation | 13 | 2020 | 454 | 0.970 |
Why?
| Otitis Media, Suppurative | 2 | 2016 | 8 | 0.930 |
Why?
| Audiometry, Pure-Tone | 17 | 2017 | 46 | 0.920 |
Why?
| Smoking | 3 | 2016 | 556 | 0.910 |
Why?
| Otosclerosis | 2 | 2020 | 9 | 0.880 |
Why?
| Costs and Cost Analysis | 3 | 2018 | 109 | 0.870 |
Why?
| Malleus | 4 | 2019 | 11 | 0.860 |
Why?
| Cleft Palate | 3 | 2021 | 72 | 0.850 |
Why?
| Audiometry | 6 | 2020 | 34 | 0.830 |
Why?
| Surgical Flaps | 4 | 2016 | 135 | 0.830 |
Why?
| Temporal Bone | 6 | 2013 | 35 | 0.800 |
Why?
| Craniocerebral Trauma | 1 | 2022 | 89 | 0.780 |
Why?
| Aged, 80 and over | 13 | 2019 | 3431 | 0.760 |
Why?
| Auditory Threshold | 8 | 2010 | 47 | 0.740 |
Why?
| Neuroma, Acoustic | 5 | 2008 | 19 | 0.720 |
Why?
| Ear Cartilage | 2 | 2016 | 5 | 0.690 |
Why?
| Follow-Up Studies | 18 | 2014 | 2387 | 0.680 |
Why?
| Neuronal Plasticity | 1 | 2019 | 58 | 0.680 |
Why?
| Patient Preference | 1 | 2019 | 38 | 0.670 |
Why?
| Intraoperative Period | 1 | 2018 | 51 | 0.650 |
Why?
| Quality of Life | 2 | 2019 | 922 | 0.650 |
Why?
| Eustachian Tube | 3 | 2023 | 15 | 0.650 |
Why?
| Neurotology | 1 | 2018 | 7 | 0.640 |
Why?
| Space Motion Sickness | 3 | 2012 | 5 | 0.620 |
Why?
| Valsalva Maneuver | 1 | 2016 | 7 | 0.580 |
Why?
| Biocompatible Materials | 5 | 2005 | 65 | 0.580 |
Why?
| Child Behavior Disorders | 1 | 2017 | 87 | 0.570 |
Why?
| Otitis Media with Effusion | 2 | 2010 | 16 | 0.570 |
Why?
| Child Behavior | 1 | 2017 | 114 | 0.570 |
Why?
| Treatment Failure | 1 | 2016 | 139 | 0.540 |
Why?
| Positron-Emission Tomography | 4 | 2011 | 322 | 0.530 |
Why?
| Temporal Lobe | 4 | 2017 | 74 | 0.530 |
Why?
| Stapes | 5 | 2020 | 13 | 0.520 |
Why?
| Vertigo | 6 | 2020 | 18 | 0.510 |
Why?
| Labyrinth Diseases | 4 | 2000 | 6 | 0.510 |
Why?
| Receptors, Atrial Natriuretic Factor | 2 | 2005 | 6 | 0.480 |
Why?
| Arousal | 5 | 2007 | 106 | 0.470 |
Why?
| Equipment Failure | 1 | 2013 | 70 | 0.470 |
Why?
| Regional Blood Flow | 2 | 2011 | 121 | 0.460 |
Why?
| Cerebellopontine Angle | 2 | 2008 | 7 | 0.450 |
Why?
| Cerebellar Neoplasms | 2 | 2008 | 23 | 0.440 |
Why?
| Recurrence | 7 | 2017 | 690 | 0.430 |
Why?
| Postoperative Period | 3 | 2019 | 189 | 0.430 |
Why?
| Audiometry, Evoked Response | 5 | 2006 | 8 | 0.420 |
Why?
| Antiemetics | 3 | 2012 | 35 | 0.400 |
Why?
| Patient Selection | 1 | 2012 | 286 | 0.390 |
Why?
| Prosthesis Implantation | 2 | 2008 | 47 | 0.390 |
Why?
| Infant | 6 | 2018 | 3817 | 0.380 |
Why?
| Evoked Potentials, Auditory | 4 | 2006 | 98 | 0.370 |
Why?
| Endolymphatic Sac | 3 | 2002 | 6 | 0.370 |
Why?
| Ear, Inner | 4 | 2013 | 18 | 0.370 |
Why?
| Chronic Disease | 6 | 2016 | 614 | 0.360 |
Why?
| Proteus mirabilis | 1 | 2009 | 2 | 0.350 |
Why?
| Bacteroidaceae Infections | 1 | 2009 | 2 | 0.350 |
Why?
| Proteus Infections | 1 | 2009 | 4 | 0.350 |
Why?
| Bacteroides | 1 | 2009 | 15 | 0.350 |
Why?
| Brain Abscess | 1 | 2009 | 11 | 0.350 |
Why?
| Cerebellar Diseases | 1 | 2009 | 18 | 0.350 |
Why?
| Fistula | 3 | 2000 | 28 | 0.340 |
Why?
| Tomography, X-Ray Computed | 8 | 2013 | 1213 | 0.330 |
Why?
| Electric Impedance | 2 | 2018 | 43 | 0.320 |
Why?
| Paraganglioma | 1 | 2008 | 12 | 0.320 |
Why?
| Succinate Dehydrogenase | 1 | 2008 | 28 | 0.320 |
Why?
| Blood Glucose | 1 | 2011 | 489 | 0.310 |
Why?
| Neoplasms, Multiple Primary | 1 | 2008 | 45 | 0.310 |
Why?
| Vestibule, Labyrinth | 2 | 2004 | 19 | 0.310 |
Why?
| DNA Mutational Analysis | 1 | 2008 | 217 | 0.300 |
Why?
| Prognosis | 6 | 2019 | 2118 | 0.300 |
Why?
| Bone Matrix | 2 | 2004 | 20 | 0.290 |
Why?
| Drainage | 3 | 2008 | 79 | 0.280 |
Why?
| Time Factors | 9 | 2013 | 3213 | 0.280 |
Why?
| Arkansas | 4 | 2017 | 2100 | 0.280 |
Why?
| Risk Factors | 6 | 2017 | 3935 | 0.280 |
Why?
| Durapatite | 2 | 2003 | 27 | 0.280 |
Why?
| Attention | 3 | 2017 | 185 | 0.280 |
Why?
| Cholesteatoma | 2 | 2012 | 6 | 0.270 |
Why?
| Atrial Natriuretic Factor | 1 | 2005 | 24 | 0.270 |
Why?
| Ear, Middle | 3 | 2018 | 17 | 0.270 |
Why?
| Prosthesis Design | 2 | 2014 | 262 | 0.260 |
Why?
| Histamine H1 Antagonists | 1 | 2004 | 9 | 0.260 |
Why?
| Posture | 2 | 2008 | 80 | 0.260 |
Why?
| GABA Modulators | 1 | 2004 | 12 | 0.250 |
Why?
| Muscarinic Antagonists | 1 | 2004 | 18 | 0.250 |
Why?
| Transplants | 1 | 2004 | 18 | 0.250 |
Why?
| Hearing Disorders | 3 | 1999 | 12 | 0.250 |
Why?
| Memory Disorders | 1 | 2004 | 62 | 0.250 |
Why?
| Genetic Predisposition to Disease | 1 | 2008 | 570 | 0.250 |
Why?
| Evoked Potentials, Auditory, Brain Stem | 6 | 2001 | 26 | 0.240 |
Why?
| Bell Palsy | 1 | 2023 | 6 | 0.240 |
Why?
| Memory, Short-Term | 1 | 2004 | 85 | 0.240 |
Why?
| Middle Ear Ventilation | 2 | 2002 | 14 | 0.240 |
Why?
| Facial Paralysis | 1 | 2023 | 24 | 0.240 |
Why?
| United States | 4 | 2023 | 5217 | 0.230 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 231 | 0.230 |
Why?
| Prostheses and Implants | 2 | 2002 | 61 | 0.230 |
Why?
| Cross-Over Studies | 4 | 2017 | 250 | 0.230 |
Why?
| Equipment Design | 4 | 2010 | 318 | 0.220 |
Why?
| Ceramics | 1 | 2002 | 10 | 0.220 |
Why?
| Decision Making | 2 | 2017 | 290 | 0.220 |
Why?
| Foreign Bodies | 1 | 2023 | 64 | 0.220 |
Why?
| Cognition Disorders | 1 | 2004 | 240 | 0.220 |
Why?
| Endoscopy | 3 | 2023 | 131 | 0.220 |
Why?
| Guanylate Cyclase | 1 | 2002 | 10 | 0.220 |
Why?
| Cicatrix | 1 | 2002 | 43 | 0.220 |
Why?
| Reaction Time | 8 | 2006 | 227 | 0.210 |
Why?
| Skull Neoplasms | 1 | 2002 | 5 | 0.210 |
Why?
| Ear, External | 1 | 2002 | 11 | 0.210 |
Why?
| Nasopharyngeal Neoplasms | 1 | 2002 | 13 | 0.210 |
Why?
| Bone Regeneration | 1 | 2002 | 71 | 0.210 |
Why?
| Noise | 2 | 2008 | 38 | 0.210 |
Why?
| Ear Neoplasms | 1 | 2002 | 12 | 0.210 |
Why?
| Action Potentials | 3 | 2017 | 131 | 0.210 |
Why?
| Speech Perception | 1 | 2022 | 90 | 0.200 |
Why?
| Incus | 2 | 2012 | 4 | 0.200 |
Why?
| Velopharyngeal Insufficiency | 1 | 2021 | 21 | 0.200 |
Why?
| Diagnosis, Differential | 3 | 2016 | 1136 | 0.190 |
Why?
| Barotrauma | 1 | 2000 | 1 | 0.190 |
Why?
| Electroencephalography | 2 | 2002 | 356 | 0.190 |
Why?
| Hospitals, University | 1 | 2000 | 89 | 0.190 |
Why?
| Sleep | 1 | 2002 | 188 | 0.190 |
Why?
| Patient Admission | 1 | 2000 | 78 | 0.180 |
Why?
| Ambulatory Surgical Procedures | 1 | 2000 | 52 | 0.180 |
Why?
| Antibodies | 2 | 2015 | 178 | 0.180 |
Why?
| Gelatin Sponge, Absorbable | 1 | 1999 | 4 | 0.180 |
Why?
| Hemostatics | 1 | 1999 | 15 | 0.180 |
Why?
| Mastoiditis | 1 | 1999 | 7 | 0.170 |
Why?
| Psychomotor Performance | 3 | 2017 | 156 | 0.170 |
Why?
| Disease Models, Animal | 3 | 2001 | 1639 | 0.170 |
Why?
| Pain Measurement | 2 | 2011 | 246 | 0.170 |
Why?
| Severity of Illness Index | 4 | 2006 | 1084 | 0.160 |
Why?
| Gerbillinae | 3 | 2003 | 9 | 0.160 |
Why?
| Operative Time | 1 | 2018 | 76 | 0.160 |
Why?
| Evoked Potentials | 1 | 2018 | 69 | 0.160 |
Why?
| Hearing Tests | 2 | 2014 | 22 | 0.160 |
Why?
| Electrophysiological Phenomena | 1 | 2017 | 20 | 0.160 |
Why?
| Pilot Projects | 4 | 2017 | 808 | 0.160 |
Why?
| Meclizine | 3 | 2012 | 5 | 0.160 |
Why?
| Hospital Costs | 1 | 2018 | 84 | 0.160 |
Why?
| Lorazepam | 3 | 2012 | 13 | 0.160 |
Why?
| Promethazine | 3 | 2012 | 11 | 0.150 |
Why?
| Fluorodeoxyglucose F18 | 2 | 2011 | 205 | 0.150 |
Why?
| Evidence-Based Medicine | 2 | 2016 | 281 | 0.150 |
Why?
| Immune System Diseases | 1 | 1997 | 10 | 0.150 |
Why?
| Risk Assessment | 2 | 2013 | 1361 | 0.150 |
Why?
| Cross-Sectional Studies | 2 | 2023 | 1693 | 0.150 |
Why?
| Algorithms | 3 | 2020 | 697 | 0.150 |
Why?
| Thalamus | 2 | 2006 | 33 | 0.140 |
Why?
| Perception | 1 | 2017 | 143 | 0.140 |
Why?
| Fibroma, Ossifying | 1 | 1995 | 2 | 0.130 |
Why?
| Fibrous Dysplasia of Bone | 1 | 1995 | 6 | 0.130 |
Why?
| Cochlear Diseases | 1 | 1995 | 4 | 0.130 |
Why?
| Nanocapsules | 1 | 2015 | 7 | 0.130 |
Why?
| Clinical Trials as Topic | 2 | 2012 | 490 | 0.130 |
Why?
| Paranasal Sinus Neoplasms | 1 | 1995 | 27 | 0.130 |
Why?
| Cochlea | 1 | 1995 | 20 | 0.130 |
Why?
| Indocyanine Green | 1 | 2015 | 39 | 0.130 |
Why?
| Rotation | 3 | 2004 | 76 | 0.130 |
Why?
| Acoustic Stimulation | 1 | 1995 | 99 | 0.130 |
Why?
| Photochemotherapy | 1 | 2015 | 37 | 0.130 |
Why?
| Magnetic Resonance Imaging | 4 | 2017 | 1604 | 0.120 |
Why?
| Second-Look Surgery | 1 | 2013 | 3 | 0.120 |
Why?
| Antigen-Antibody Complex | 1 | 1993 | 39 | 0.120 |
Why?
| Biofeedback, Psychology | 1 | 2013 | 16 | 0.120 |
Why?
| Electric Stimulation | 1 | 2013 | 95 | 0.120 |
Why?
| Dilatation | 2 | 2023 | 27 | 0.120 |
Why?
| Research Design | 2 | 2013 | 374 | 0.110 |
Why?
| Vestibular Diseases | 1 | 1993 | 8 | 0.110 |
Why?
| Age Factors | 2 | 2010 | 1198 | 0.110 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2016 | 596 | 0.110 |
Why?
| Bone Demineralization Technique | 2 | 2004 | 3 | 0.110 |
Why?
| Wound Healing | 3 | 2003 | 228 | 0.110 |
Why?
| Animals | 8 | 2023 | 14385 | 0.110 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 126 | 0.110 |
Why?
| Catheterization | 2 | 2023 | 108 | 0.110 |
Why?
| Saccule and Utricle | 1 | 2012 | 2 | 0.110 |
Why?
| Reflex, Vestibulo-Ocular | 1 | 2012 | 5 | 0.110 |
Why?
| Functional Laterality | 2 | 2012 | 99 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 673 | 0.100 |
Why?
| Prospective Studies | 1 | 2018 | 2604 | 0.100 |
Why?
| Postoperative Care | 2 | 2003 | 121 | 0.100 |
Why?
| Round Window, Ear | 2 | 2005 | 5 | 0.100 |
Why?
| Dose-Response Relationship, Drug | 2 | 2005 | 1476 | 0.100 |
Why?
| Fibrosis | 3 | 2012 | 208 | 0.100 |
Why?
| Databases, Factual | 2 | 2023 | 684 | 0.090 |
Why?
| Suture Anchors | 1 | 2010 | 15 | 0.090 |
Why?
| Cognition | 1 | 2013 | 348 | 0.090 |
Why?
| Prefrontal Cortex | 3 | 2017 | 89 | 0.090 |
Why?
| Vestibular Function Tests | 2 | 2012 | 8 | 0.090 |
Why?
| Infusions, Intravenous | 2 | 2009 | 231 | 0.090 |
Why?
| Case-Control Studies | 2 | 2006 | 1228 | 0.090 |
Why?
| Logistic Models | 1 | 2012 | 995 | 0.090 |
Why?
| Facial Nerve | 2 | 2023 | 19 | 0.090 |
Why?
| Granulation Tissue | 1 | 2009 | 12 | 0.090 |
Why?
| Databases as Topic | 2 | 2000 | 46 | 0.090 |
Why?
| Double-Blind Method | 2 | 2017 | 742 | 0.090 |
Why?
| Speech Intelligibility | 1 | 2008 | 15 | 0.080 |
Why?
| Television | 1 | 2008 | 17 | 0.080 |
Why?
| Equipment Safety | 1 | 2008 | 16 | 0.080 |
Why?
| Transcutaneous Electric Nerve Stimulation | 1 | 2008 | 8 | 0.080 |
Why?
| Dominance, Cerebral | 1 | 2008 | 28 | 0.080 |
Why?
| Otitis Media | 1 | 2008 | 29 | 0.080 |
Why?
| Retreatment | 1 | 2008 | 57 | 0.080 |
Why?
| Consensus | 2 | 2020 | 157 | 0.080 |
Why?
| Proline | 1 | 2008 | 31 | 0.080 |
Why?
| Reading | 1 | 2008 | 84 | 0.080 |
Why?
| Secondary Prevention | 1 | 2008 | 89 | 0.080 |
Why?
| Codon | 1 | 2008 | 48 | 0.080 |
Why?
| Eating | 1 | 2008 | 155 | 0.080 |
Why?
| Amino Acid Substitution | 1 | 2008 | 105 | 0.080 |
Why?
| Activities of Daily Living | 1 | 2008 | 204 | 0.080 |
Why?
| Leucine | 1 | 2008 | 113 | 0.080 |
Why?
| Appendicitis | 1 | 1988 | 77 | 0.070 |
Why?
| Brain Stem | 2 | 2006 | 46 | 0.070 |
Why?
| Chromosome Deletion | 1 | 2008 | 150 | 0.070 |
Why?
| Alleles | 1 | 2008 | 277 | 0.070 |
Why?
| Feasibility Studies | 1 | 2008 | 398 | 0.070 |
Why?
| Auditory Cortex | 1 | 2006 | 22 | 0.070 |
Why?
| Autoantibodies | 2 | 1997 | 132 | 0.070 |
Why?
| Therapy, Computer-Assisted | 1 | 2006 | 34 | 0.070 |
Why?
| Base Sequence | 1 | 2008 | 719 | 0.070 |
Why?
| Radiography | 1 | 2008 | 524 | 0.070 |
Why?
| Radiosurgery | 1 | 2008 | 122 | 0.070 |
Why?
| Genotype | 1 | 2008 | 599 | 0.070 |
Why?
| Energy Metabolism | 1 | 2008 | 311 | 0.070 |
Why?
| Silicones | 1 | 2005 | 9 | 0.070 |
Why?
| Connective Tissue | 2 | 1997 | 23 | 0.070 |
Why?
| Task Performance and Analysis | 1 | 2006 | 61 | 0.070 |
Why?
| Dermatitis, Allergic Contact | 1 | 2005 | 18 | 0.070 |
Why?
| Electrophoresis, Agar Gel | 1 | 2005 | 12 | 0.070 |
Why?
| Buffers | 1 | 2005 | 10 | 0.070 |
Why?
| Cerebrospinal Fluid Otorrhea | 2 | 1995 | 3 | 0.070 |
Why?
| Injections | 1 | 2005 | 61 | 0.070 |
Why?
| Rats, Inbred Lew | 1 | 2005 | 67 | 0.070 |
Why?
| Phosphates | 1 | 2005 | 51 | 0.070 |
Why?
| Cohort Studies | 2 | 2013 | 1543 | 0.070 |
Why?
| Radiopharmaceuticals | 1 | 2006 | 238 | 0.070 |
Why?
| Prednisolone | 2 | 1995 | 57 | 0.060 |
Why?
| Drug Combinations | 1 | 2005 | 128 | 0.060 |
Why?
| Sodium Chloride | 1 | 2005 | 67 | 0.060 |
Why?
| Protein Isoforms | 1 | 2005 | 124 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2009 | 539 | 0.060 |
Why?
| Pregnancy Complications | 1 | 1988 | 384 | 0.060 |
Why?
| Single-Blind Method | 2 | 2013 | 120 | 0.060 |
Why?
| Up-Regulation | 1 | 2005 | 508 | 0.060 |
Why?
| Rats | 3 | 2005 | 3415 | 0.060 |
Why?
| Neuropsychological Tests | 1 | 2004 | 363 | 0.060 |
Why?
| Bone Substitutes | 1 | 2002 | 12 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2009 | 820 | 0.060 |
Why?
| Matched-Pair Analysis | 1 | 2002 | 12 | 0.050 |
Why?
| Motion Sickness | 1 | 2002 | 9 | 0.050 |
Why?
| Reticular Formation | 1 | 2002 | 23 | 0.050 |
Why?
| Swine | 1 | 2023 | 431 | 0.050 |
Why?
| Nausea | 1 | 2002 | 52 | 0.050 |
Why?
| Graft Survival | 1 | 2002 | 165 | 0.050 |
Why?
| RNA, Messenger | 1 | 2005 | 1202 | 0.050 |
Why?
| Immunohistochemistry | 2 | 2002 | 1089 | 0.050 |
Why?
| Pharynx | 1 | 2021 | 39 | 0.050 |
Why?
| Homeostasis | 1 | 2002 | 223 | 0.050 |
Why?
| Cochlear Aqueduct | 1 | 2000 | 1 | 0.050 |
Why?
| Anesthetics | 1 | 2000 | 36 | 0.050 |
Why?
| Analysis of Variance | 1 | 2001 | 635 | 0.040 |
Why?
| Preoperative Care | 1 | 2000 | 184 | 0.040 |
Why?
| Endolymphatic Hydrops | 1 | 1998 | 3 | 0.040 |
Why?
| Skull Base | 1 | 1999 | 32 | 0.040 |
Why?
| Neoplasm Staging | 1 | 2002 | 806 | 0.040 |
Why?
| International Agencies | 1 | 2018 | 14 | 0.040 |
Why?
| Surface Tension | 1 | 1998 | 1 | 0.040 |
Why?
| Bone and Bones | 1 | 2002 | 516 | 0.040 |
Why?
| Brain | 1 | 2007 | 1387 | 0.040 |
Why?
| Speech Discrimination Tests | 2 | 1994 | 5 | 0.040 |
Why?
| Acoustics | 1 | 1998 | 38 | 0.040 |
Why?
| Neurosurgical Procedures | 1 | 1999 | 120 | 0.040 |
Why?
| Internationality | 1 | 2018 | 49 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2002 | 1304 | 0.040 |
Why?
| Parietal Lobe | 1 | 2017 | 30 | 0.040 |
Why?
| Immunoglobulins | 1 | 1997 | 89 | 0.040 |
Why?
| Societies, Medical | 1 | 2018 | 194 | 0.040 |
Why?
| Disease Progression | 1 | 2000 | 913 | 0.040 |
Why?
| Food Hypersensitivity | 1 | 1997 | 96 | 0.040 |
Why?
| Autoimmune Diseases | 1 | 1997 | 114 | 0.030 |
Why?
| Premedication | 1 | 1995 | 18 | 0.030 |
Why?
| Perilymph | 1 | 1995 | 2 | 0.030 |
Why?
| Bone Cysts, Aneurysmal | 1 | 1995 | 5 | 0.030 |
Why?
| Nystagmus, Pathologic | 1 | 1995 | 7 | 0.030 |
Why?
| Electronystagmography | 1 | 1995 | 1 | 0.030 |
Why?
| Speech Reception Threshold Test | 1 | 1995 | 1 | 0.030 |
Why?
| Brain Neoplasms | 1 | 1999 | 284 | 0.030 |
Why?
| Ethmoid Sinus | 1 | 1995 | 14 | 0.030 |
Why?
| Fibrin Tissue Adhesive | 1 | 1995 | 12 | 0.030 |
Why?
| Cochlear Microphonic Potentials | 1 | 1995 | 1 | 0.030 |
Why?
| Organ of Corti | 1 | 1995 | 1 | 0.030 |
Why?
| Myelography | 1 | 1995 | 2 | 0.030 |
Why?
| Frontal Sinus | 1 | 1995 | 9 | 0.030 |
Why?
| Guinea Pigs | 1 | 1995 | 89 | 0.030 |
Why?
| Bone Transplantation | 1 | 1995 | 55 | 0.030 |
Why?
| Hearing Loss, Central | 1 | 1994 | 4 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 1995 | 232 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2018 | 492 | 0.030 |
Why?
| Keratinocytes | 1 | 2015 | 96 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2017 | 1048 | 0.030 |
Why?
| Electrooculography | 1 | 1993 | 14 | 0.030 |
Why?
| Control Groups | 1 | 2013 | 10 | 0.030 |
Why?
| Sex Factors | 2 | 1995 | 767 | 0.030 |
Why?
| Anti-Inflammatory Agents | 1 | 1995 | 175 | 0.030 |
Why?
| Linear Models | 1 | 1994 | 309 | 0.030 |
Why?
| Epithelium | 1 | 1993 | 68 | 0.030 |
Why?
| Reference Values | 1 | 1994 | 354 | 0.030 |
Why?
| Myringoplasty | 1 | 2013 | 3 | 0.030 |
Why?
| Fascia | 1 | 2013 | 6 | 0.030 |
Why?
| Immunoenzyme Techniques | 1 | 1993 | 165 | 0.030 |
Why?
| Gambling | 1 | 2013 | 19 | 0.030 |
Why?
| Blood Vessels | 1 | 1993 | 78 | 0.030 |
Why?
| Immunoglobulin G | 1 | 1993 | 226 | 0.030 |
Why?
| Data Interpretation, Statistical | 1 | 2013 | 177 | 0.030 |
Why?
| Impulsive Behavior | 1 | 2013 | 82 | 0.030 |
Why?
| Reward | 1 | 2013 | 123 | 0.030 |
Why?
| Collagen | 1 | 1993 | 223 | 0.030 |
Why?
| Choice Behavior | 1 | 2013 | 95 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 1994 | 923 | 0.030 |
Why?
| Cadaver | 1 | 2012 | 113 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2002 | 1663 | 0.020 |
Why?
| Device Removal | 1 | 2005 | 97 | 0.020 |
Why?
| Habituation, Psychophysiologic | 1 | 2002 | 31 | 0.010 |
Why?
| Electromyography | 1 | 2002 | 150 | 0.010 |
Why?
| Pregnancy | 1 | 1988 | 2620 | 0.010 |
Why?
| Osteocytes | 1 | 2001 | 220 | 0.010 |
Why?
| Osteogenesis | 1 | 2001 | 377 | 0.010 |
Why?
| Survival Rate | 1 | 1999 | 951 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1997 | 198 | 0.010 |
Why?
| Headache | 1 | 1995 | 78 | 0.010 |
Why?
| Craniotomy | 1 | 1994 | 25 | 0.010 |
Why?
|
|
Dornhoffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Same Department
People who are also in this person's primary department.
|